Maternal Mortality resources: Amniotic Embolism

Publication
Article
Contemporary OB/GYN JournalVol. 64 No. 07
Volume 64
Issue 7

A collection of standards, guidelines, tools and articles for the OB managing amniotic embolism. Plus: A recently published study from our Maternal Mortality Series Editor, Carolyn Zelop, MD, along with Stephanie Martin, DO, that discusses the specifics of dealing with maternal cardiac arrest that occurs during pregnancy.

Having trouble viewing?

Trouble viewing this PDF?

Once you access the file, position your mouse over the top middle for a toolbar:

Download Issue PDF
Articles in this issue
Maternal Mortality resources: Amniotic Embolism
Genitourinary syndrome of menopause: Underdiagnosed and undertreated
Long-term maternal benefits of breastfeeding
Oxytocin suspect in cases with poor outcomes
C-section
ERAS: Improved outcomes post-cesarean
Fertility banking – how secure is it?
Managing obstetric emergencies: Anaphylactoid syndrome of pregnancy (aka AFE)
Managing obstetric emergencies: Anaphylactoid syndrome of pregnancy (aka AFE)
Recent Videos
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Lauren Streicher, MD
JoAnne Pinkerton, MD, FACOG, NCMP
Nannette Santoro, MD
Lauren Streicher, MD
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Related Content
FDA updates warning for liver injury due to fezolinetant

FDA updates warning for liver injury due to fezolinetant

Kevin Kunzmann
September 13th 2024
Article

The FDA upped the recommended rate of liver blood tests for patients initiating fezolinetant on the basis of a post-marketing case report involving serious liver injury.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances | Image Credit: © stokkete - © Jstokkete - stock.adobe.com.

SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances

Celeste Krewson, Assistant Editor
September 13th 2024
Article

At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.

Read More

Site Logo

The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels

September 15th 2023
Podcast

Listen

Image credit: © highwaystarz - stock.adobe.com.

Study shows hormone therapy offers lasting benefits for women over 65

Morgan Petronelli, Managing Editor
September 12th 2024
Article

A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.

Read More

Daniel Jiang, MD, PhD | Image Credit: TowerHealth.org

Hormone therapy associated with reduced insulin resistance

Celeste Krewson, Assistant Editor;Joshua Fitch, Senior Editor
September 12th 2024
Article

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, insulin resistance was significantly reduced among postmenopausal women receiving hormone therapy vs placebo.

Read More

© 2024 MJH Life Sciences

All rights reserved.